Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances R Balkwill

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
STAR Protocols|January 24, 2022
Building <i>in</i><i>vitro</i> 3D human multicellular models of high-grade serous ovarian cancerBeatrice Malacrida, Oliver M T Pearce, Frances R Balkwill
Cancer Research|November 17, 2005
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cellsHagen Kulbe, Thorsten Hagemann, Piotr W Szlosarek, et al.
Carcinogenesis|March 27, 2004
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteasesThorsten Hagemann, Stephen C Robinson, Matthias Schulz, et al.
Molecular Cancer Therapeutics|July 11, 2007
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesisThorsten Hagemann, Stephen C Robinson, Richard G Thompson, et al.
Cancer Research|April 3, 2004
A role for endothelin-2 and its receptors in breast tumor cell invasionMatthew J Grimshaw, Thorsten Hagemann, Ayse Ayhan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Vaccinia virus induces programmed necrosis in ovarian cancer cellsLynsey M Whilding, Kyra M Archibald, Hagen Kulbe, et al.
Oncogene|December 9, 2003
Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour developmentCaroline H Arnott, Kate A Scott, Robert J Moore, et al.
Cancer Research|December 18, 2003
A chemokine receptor antagonist inhibits experimental breast tumor growthStephen C Robinson, Kate A Scott, Julia L Wilson, et al.
Molecular Cancer Therapeutics|March 1, 2006
Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epitheliumPeter W Szlosarek, Matthew J Grimshaw, Hagen Kulbe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Ovarian cancer cells polarize macrophages toward a tumor-associated phenotypeThorsten Hagemann, Julia Wilson, Frances Burke, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
STAR Protocols|January 24, 2022
Building <i>in</i><i>vitro</i> 3D human multicellular models of high-grade serous ovarian cancerBeatrice Malacrida, Oliver M T Pearce, Frances R Balkwill
Cancer Research|November 17, 2005
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cellsHagen Kulbe, Thorsten Hagemann, Piotr W Szlosarek, et al.
Carcinogenesis|March 27, 2004
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteasesThorsten Hagemann, Stephen C Robinson, Matthias Schulz, et al.
Molecular Cancer Therapeutics|July 11, 2007
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesisThorsten Hagemann, Stephen C Robinson, Richard G Thompson, et al.
Cancer Research|April 3, 2004
A role for endothelin-2 and its receptors in breast tumor cell invasionMatthew J Grimshaw, Thorsten Hagemann, Ayse Ayhan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Vaccinia virus induces programmed necrosis in ovarian cancer cellsLynsey M Whilding, Kyra M Archibald, Hagen Kulbe, et al.
Oncogene|December 9, 2003
Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour developmentCaroline H Arnott, Kate A Scott, Robert J Moore, et al.
Cancer Research|December 18, 2003
A chemokine receptor antagonist inhibits experimental breast tumor growthStephen C Robinson, Kate A Scott, Julia L Wilson, et al.
Molecular Cancer Therapeutics|March 1, 2006
Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epitheliumPeter W Szlosarek, Matthew J Grimshaw, Hagen Kulbe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Ovarian cancer cells polarize macrophages toward a tumor-associated phenotypeThorsten Hagemann, Julia Wilson, Frances Burke, et al.
Pageof 8